Skip to content

Clinical trials

Prostatic Hyperplasia trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Country / region: Italy Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20053
20071
20081
20094
20106
20112
20122
20131
20143
20152
20162
20183
20193
20201
20212
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Unknown status4
Recruiting3
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company6
GlaxoSmithKline4
University of Florence4
Astellas Pharma Europe B.V.2
IRCCS San Raffaele2
Pierre Fabre Medicament2
San Carlo di Nancy Hospital2
Société Internationale d'Urologie2
University of Pisa2
AEterna Zentaris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia42
Lower Urinary Tract Symptoms13
Hypogonadism2
Prostatic Diseases2
Catheter-Related Infections1
Erectile Dysfunction1
Genital Diseases, Male1
Hyperplasia1
Inflammation1
Insulin Resistance1

Trials

Showing 26 to 42 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.